RELINIFY Trademark

Trademark Overview


On Tuesday, September 13, 2022, a trademark application was filed for RELINIFY with the United States Patent and Trademark Office. The USPTO has given the RELINIFY trademark a serial number of 97589986. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Thursday, November 21, 2024. This trademark is owned by Protagonist Therapeutics, Inc.. The RELINIFY trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Pharmaceuticals for use in the treatment of cancer and blood diseases and disorders

Medical information services in the fields of pharmaceuticals, oncology, and blood diseases and disorders

Medical research and medical research information services in the fields of pharmaceuticals, oncology, and blood diseases and disorders
relinify

General Information


Serial Number97589986
Word MarkRELINIFY
Filing DateTuesday, September 13, 2022
Status731 - SECOND EXTENSION - GRANTED
Status DateThursday, November 21, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 29, 2023

Trademark Statements


Goods and ServicesPharmaceuticals for use in the treatment of cancer and blood diseases and disorders
Goods and ServicesMedical information services in the fields of pharmaceuticals, oncology, and blood diseases and disorders
Goods and ServicesMedical research and medical research information services in the fields of pharmaceuticals, oncology, and blood diseases and disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, September 28, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, September 28, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, July 18, 2023
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameTAKEDA PHARMACEUTICALS U.S.A., INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressCAMBRIDGE, MA 02142

Party NameProtagonist Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNewark, CA 94560-1160

Party NameProtagonist Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNewark, CA 945601160

Trademark Events


Event DateEvent Description
Wednesday, September 28, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, September 16, 2022NEW APPLICATION ENTERED
Thursday, January 5, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, January 5, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, January 5, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sunday, June 25, 2023ASSIGNED TO EXAMINER
Monday, June 26, 2023NON-FINAL ACTION WRITTEN
Monday, June 26, 2023NON-FINAL ACTION E-MAILED
Monday, June 26, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, July 17, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, July 17, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 18, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, July 20, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 29, 2023PUBLISHED FOR OPPOSITION
Tuesday, August 29, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, August 9, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 24, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 12, 2024SOU EXTENSION 1 GRANTED
Tuesday, March 12, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, March 12, 2024SOU EXTENSION 1 FILED
Thursday, October 17, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, October 17, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, October 18, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, March 13, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 17, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, October 18, 2024SOU EXTENSION 2 FILED
Thursday, November 21, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, November 22, 2024SOU EXTENSION 2 GRANTED
Friday, November 22, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 23, 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP